US Dollar vs Yen

登録してリアルタイムのチャート、分析ツール、価格を入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Silverback Therapeutics Inc (SBTX)
Silverback Therapeutics Inc (SBTX) ニュース

SBTX

Silverback Therapeutics (SBTX)

Silverback Therapeutics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:SBTX

1 2 3 4 5 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2023/06/29	05 : 32	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SBTX	Silverback Therapeutics Inc
2023/05/15	22 : 08	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:SBTX	Silverback Therapeutics Inc
2023/05/15	22 : 06	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SBTX	Silverback Therapeutics Inc
2023/05/09	22 : 13	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SBTX	Silverback Therapeutics Inc
2023/05/09	05 : 35	Edgar (US Regulatory)	Report of Proposed Sale of Securities (144)	NASDAQ:SBTX	Silverback Therapeutics Inc
2023/05/02	05 : 42	Edgar (US Regulatory)	Annual Report to Security Holders (ars)	NASDAQ:SBTX	Silverback Therapeutics Inc
2023/05/02	05 : 31	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:SBTX	Silverback Therapeutics Inc
2023/03/24	05 : 14	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:SBTX	Silverback Therapeutics Inc
2023/03/24	05 : 12	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SBTX	Silverback Therapeutics Inc
2023/03/13	22 : 29	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SBTX	Silverback Therapeutics Inc
2023/02/24	06 : 01	GlobeNewswire Inc.	ARS Pharmaceuticals Announces Presentation of Data Supporting neffy (epinephrine nasal spray) and Real-World Burden of Needle Injectors	NASDAQ:SBTX	Silverback Therapeutics Inc
2023/02/23	06 : 12	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SBTX	Silverback Therapeutics Inc
2023/02/23	06 : 05	GlobeNewswire Inc.	ARS Pharmaceuticals Reacquires European Marketing Rights to neffy® (ARS-1) for the Treatment of Type I Allergic Reactions Including Anaphylaxis	NASDAQ:SBTX	Silverback Therapeutics Inc
2023/02/14	06 : 33	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:SBTX	Silverback Therapeutics Inc
2023/02/09	20 : 30	GlobeNewswire Inc.	ARS Pharmaceuticals to Participate in the SVB Securities Virtual Global Biopharma Conference 2023	NASDAQ:SBTX	Silverback Therapeutics Inc
2023/01/18	07 : 07	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	NASDAQ:SBTX	Silverback Therapeutics Inc
2023/01/18	06 : 31	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:SBTX	Silverback Therapeutics Inc
2023/01/06	07 : 02	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SBTX	Silverback Therapeutics Inc
2023/01/06	07 : 02	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SBTX	Silverback Therapeutics Inc
2023/01/06	07 : 02	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SBTX	Silverback Therapeutics Inc
2023/01/06	07 : 01	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SBTX	Silverback Therapeutics Inc
2023/01/06	07 : 01	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SBTX	Silverback Therapeutics Inc
2023/01/06	07 : 01	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SBTX	Silverback Therapeutics Inc
2023/01/06	07 : 01	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SBTX	Silverback Therapeutics Inc
2022/12/10	07 : 04	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SBTX	Silverback Therapeutics Inc
2022/12/07	07 : 08	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SBTX	Silverback Therapeutics Inc
2022/12/02	06 : 32	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SBTX	Silverback Therapeutics Inc
2022/12/01	06 : 24	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:SBTX	Silverback Therapeutics Inc
2022/11/22	06 : 08	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	NASDAQ:SBTX	Silverback Therapeutics Inc
2022/11/19	07 : 07	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	NASDAQ:SBTX	Silverback Therapeutics Inc

Showing the most relevant articles for your search:NASDAQ:SBTX

1 2 3 4 5 次へ >>

Health Care Select Sector

Financial Select Sector

BNP Paribas (QX)

US Dollar vs Sterling

JP Morgan Chase

American Express

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約